Entering text into the input field will update the search result below

Avanir Pharmaceuticals misses by $0.01, misses on revenue

May 06, 2014 4:14 PM ETAvanir Pharmaceuticals, Inc (AVNR) StockBy: Mohit Manghnani, SA News Editor
  • Avanir Pharmaceuticals (NASDAQ:AVNR): FQ2 EPS of -$0.08 misses by $0.01.
  • Revenue of $26.9M (+54.3% Y/Y) misses by $1.31M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AVNR--
Avanir Pharmaceuticals, Inc